Porsche AG confirmed its full-year guidance as the German luxury sports-car maker continued to reap early benefits from a ...

President Trump escalated his attacks on Democratic Senate nominee Abdul El-Sayed, linking him to the Muslim Brotherhood and ...

EXCLUSIVE: The U.K. drugmaker currently has five approved cancer medicines and a clinical-stage portfolio of about 15 assets.

The investment comes as Nvidia and Meta Platforms expand their partnership on the Facebook parent’s artificial-intelligence ...

The Cronos project off Cyprus in the eastern Mediterranean lays the foundation for future drilling in the region, according ...

The Swiss drugmaker cited solid sales growth and productivity gains, even as recent clinical-trial setbacks hit its bottom line in the third quarter.

The bank said quarterly results were supported by growth in banking net interest income and lower expected credit losses.

Oil prices fell as traders weighed fresh regional efforts to ease tensions involving Iran against Houthi attacks on Saudi Arabia and risks to shipping through the Hormuz Strait.

A Deloitte study found a booming market in stock-based loans to billionaires—and the lesser rich.

Software firms account for about a third of the risky corporate loans due in 2028 and 2029.

The Democrat running for Senate says he rejects the “progressive” label, but hasn’t changed his beliefs.

The order comes in a legal fight over Trump’s renovation plan and requires the government to give notice before closing or ...